Home/Filings/4/0001209191-22-000387
4//SEC Filing

Doraiswamy Vinayak 4

Accession 0001209191-22-000387

CIK 0001323885other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 8:39 AM ET

Size

5.0 KB

Accession

0001209191-22-000387

Insider Transaction Report

Form 4
Period: 2021-12-31
Doraiswamy Vinayak
Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2021-12-31$59.10/sh+24$1,41816,899 total
Footnotes (2)
  • [F1]Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2021.
  • [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on December 31, 2021, which was the last trading day of the applicable offering period. The closing price on December 31, 2021 was $69.53.

Issuer

AtriCure, Inc.

CIK 0001323885

Entity typeother

Related Parties

1
  • filerCIK 0001862458

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 8:39 AM ET
Size
5.0 KB